Acrivon Therapeutics Inc....
5.59
0.03 (0.54%)
At close: Jan 15, 2025, 2:10 PM

Ratios (Annual)

Discover comprehensive ratio statement breakdowns that reveal insights into revenue, expenses, and beyond.
Year FY23 FY22 FY21 FY20
PE Ratio -1.8 -8.51 -21.37 -65.42
PS Ratio n/a n/a n/a n/a
PB Ratio 0.90 1.48 -14.58 -41.26
P/FCF Ratio -2.47 -7.82 -24.41 -123.18
P/OCF Ratio -2.55 -8.38 -24.83 -123.83
OCF/S Ratio n/a n/a n/a n/a
Debt / Equity Ratio 0.04 0.03 -0.24 -0.01
Quick Ratio 9.75 19.61 34.46 2.80
Current Ratio 9.75 19.61 34.46 2.80
Asset Turnover n/a n/a n/a n/a
Interest Coverage n/a n/a n/a n/a
Return on Equity (ROE) -0.5 -0.17 0.68 0.63
Return on Assets (ROA) -0.44 -0.16 -0.15 -2.43
Return on Capital (ROIC) -0.54 -0.19 -0.16 -2.02
Dividend Yield n/a n/a n/a n/a
Payout Ratio n/a n/a n/a n/a
Gross Profit Margin n/a n/a n/a n/a
Net Profit Margin n/a n/a n/a n/a
Pretax Profit Margin n/a n/a n/a n/a
Operating Profit Margin n/a n/a n/a n/a
FCF Margin n/a n/a n/a n/a
EBITDA Margin n/a n/a n/a n/a